Russell Investments Group, Ltd. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6,002,659
+184.6%
130,521
+255.6%
0.01%
+200.0%
Q2 2023$2,109,378
+55.3%
36,704
+1.3%
0.00%
+33.3%
Q1 2023$1,358,099
-33.7%
36,216
-50.5%
0.00%
-25.0%
Q4 2022$2,048,316
+2.2%
73,102
+2.4%
0.00%0.0%
Q3 2022$2,004,000
-74.7%
71,394
-68.7%
0.00%
-75.0%
Q2 2022$7,922,000
+43.0%
227,809
+47.6%
0.02%
+60.0%
Q1 2022$5,538,000
+85.5%
154,339
+20.4%
0.01%
+100.0%
Q4 2021$2,985,000
-6.7%
128,221
-23.9%
0.01%0.0%
Q3 2021$3,199,000
+45600.0%
168,405
+42970.3%
0.01%
Q2 2021$7,000
-98.9%
391
-98.9%
0.00%
-100.0%
Q1 2021$657,000
+284.2%
35,898
+317.5%
0.00%
Q4 2020$171,000
+6.9%
8,5990.0%0.00%
Q3 2020$160,000
-60.7%
8,599
-52.6%
0.00%
-100.0%
Q2 2020$407,000
+253.9%
18,156
+132.8%
0.00%
Q1 2020$115,000
-63.7%
7,800
-51.2%
0.00%
-100.0%
Q3 2019$317,000
-32.8%
16,000
-28.6%
0.00%0.0%
Q2 2019$472,000
+19.8%
22,400
+16.1%
0.00%0.0%
Q1 2019$394,000
+4.5%
19,300
+1.7%
0.00%0.0%
Q4 2018$377,000
+292.7%
18,971
+281.6%
0.00%
Q3 2018$96,000
-51.8%
4,971
-62.0%
0.00%
Q2 2018$199,000
-78.2%
13,071
-73.5%
0.00%
-100.0%
Q1 2018$911,000
-26.4%
49,320
-21.3%
0.00%0.0%
Q4 2017$1,237,000
+0.2%
62,640
-9.4%
0.00%0.0%
Q3 2017$1,235,000
-4.6%
69,127
-4.6%
0.00%0.0%
Q2 2017$1,295,000
-40.5%
72,466
-51.7%
0.00%
-50.0%
Q1 2017$2,176,000
-62.7%
150,090
-52.7%
0.00%
-63.6%
Q4 2016$5,829,000317,1350.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders